Versant Venture Management

Latest statistics and disclosures from Versant Venture Management's latest quarterly 13F-HR filing:

Companies in the Versant Venture Management portfolio as of September 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Crispr Therapeutics Ag 67.15 4.23M 40.99
Veracyte 11.19 1.21M -50% 24.00
Gritstone Oncology Ord 10.37 3.10M 8.63
Audentes Therapeutics Inc Com stock 6.02 553916 28.09
Ocular Therapeutix 2.61 2.22M 3.04
Second Sight Med Prods 1.43 4.49M 0.82
Cymabay Therapeutics 1.08 543753 5.12
Clovis Oncology 0.15 101855 3.93

Past 13F-HR SEC Filings by Versant Venture Management

View All Filings